Biosyent Inc (TSXV:RX)
C$ 11 -0.15 (-1.35%) Market Cap: 127.46 Mil Enterprise Value: 111.19 Mil PE Ratio: 18.36 PB Ratio: 3.60 GF Score: 96/100

Biosyent Inc Annual Shareholders Meeting Transcript

May 26, 2021 / 01:00PM GMT
Release Date Price: C$7.5 (-1.32%)
RenÃ;C. Goehrum
BioSyent Inc. - Chairman, CEO & President

© -

Good morning. The meeting will now come to order. My name is René Goehrum, Chairman of the Board of Directors of the company. Welcome to the Annual General and Special Meeting of the shareholders of BioSyent Inc. This meeting is also being webcast live on the BioSyent Inc. corporate website.

Welcome to those shareholders viewing this meeting by webcast. You've been muted. But you will have an opportunity to submit questions following the formal portion of the meeting. If you get disconnected for any reason during the meeting, simply click on the webcast link available on the biosyent.com homepage to reconnect.

With the consent of the meeting, I will act as Chairman; and Robert March, the Chief Financial Officer of the company, will act as secretary of the meeting.

Also joining us here today in person are directors, Mr. Peter Lockhard, and Mr. Steve Wilton. With the concurrence of the meeting, I appoint Roxanne Parsaud of Computershare to act as the scrutineer.

The notice calling this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot